Literature DB >> 29869839

Proinflammatory CX3CR1+CD59+Tumor Necrosis Factor-Like Molecule 1A+Interleukin-23+ Monocytes Are Expanded in Patients With Ankylosing Spondylitis and Modulate Innate Lymphoid Cell 3 Immune Functions.

Francesco Ciccia1, Giuliana Guggino1, Michael Zeng2, Ranjeny Thomas3, Vidya Ranganathan, Arifur Rahman3, Riccardo Alessandro4, Aroldo Rizzo1, Laura Saieva4, Federica Macaluso1, Sergio Peralta1, Diana Di Liberto4, Francesco Dieli4, Paola Cipriani5, Roberto Giacomelli5, Dominique Baeten6, Nigil Haroon7.   

Abstract

OBJECTIVE: Gut-derived innate lymphoid cell 3 (ILC3) has been shown to participate in the pathogenesis of ankylosing spondylitis (AS). CX3 CR1+ mononuclear phagocytes (MNPs) have been demonstrated to modulate ILC3 function in the gut. This study was undertaken to investigate the role of proinflammatory CX3 CR1+CD59+ MNPs in modulating ILC3 function in AS patients.
METHODS: MNP subsets in the blood of AS patients and controls were analyzed by flow cytometry. The presence of CX3 CR1+CD59+ cells in tissue was confirmed by confocal microscopy. Expression of the proinflammatory chemokines CX3 CL1 and CCL2 and decoy receptor 6 (DcR-6) was analyzed. Peripheral CX3 CR1+CD59+ cells were cocultured with ILC3, and changes in their frequency were evaluated by flow cytometry. Transcriptome analysis of circulating CX3 CR1+ monocytes was also performed.
RESULTS: DcR-6 deficiency and CCL2 overexpression were observed in inflamed tissues from AS patients. In the gut, the proinflammatory CX3 CR1+CD59+ MNP population was expanded, correlated with the presence of bacteria, and produced high levels of tumor necrosis factor-like molecule 1A (TL1A) and interleukin-23 (IL-23). MNPs positive for CD11b, CD11c, and major histocompatibility complex class II, predominantly expressing CX3 CR1, were also expanded in the small intestines of treatment-naive SKG relative to BALB/c mice. The frequency of gut-derived CX3 CR1+CD59+CCR9+TL1A+IL-23+ MNPs was significantly higher in the peripheral blood and synovial fluid of AS patients than controls. CCR9+CX3 CR1+CD59+ monocytes were also expanded in AS synovial and bone marrow samples. Transcriptome analysis of isolated CX3 CR1+CD59+ monocytes demonstrated a specific proinflammatory profile in AS. Isolated proinflammatory CX3 CR1+CD59+ MNPs from AS patients induced the expansion and activation of ILC3.
CONCLUSION: Proinflammatory CX3 CR1+CD59+TL1A+IL-23+ MNPs are expanded in AS patients and display a specific proinflammatory transcriptome profile. Given the ability of these cells to support ILC3 expansion, they may promote a sustained proinflammatory status in AS.
© 2018, American College of Rheumatology.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29869839     DOI: 10.1002/art.40582

Source DB:  PubMed          Journal:  Arthritis Rheumatol        ISSN: 2326-5191            Impact factor:   10.995


  14 in total

Review 1.  The balance of power: innate lymphoid cells in tissue inflammation and repair.

Authors:  Jim G Castellanos; Randy S Longman
Journal:  J Clin Invest       Date:  2019-06-10       Impact factor: 14.808

Review 2.  Revisiting the gut-joint axis: links between gut inflammation and spondyloarthritis.

Authors:  Eric Gracey; Lars Vereecke; Dermot McGovern; Mareike Fröhling; Georg Schett; Silvio Danese; Martine De Vos; Filip Van den Bosch; Dirk Elewaut
Journal:  Nat Rev Rheumatol       Date:  2020-07-13       Impact factor: 20.543

Review 3.  ILC3 in Axial Spondyloarthritis: the Gut Angle.

Authors:  Daniele Mauro; Federica Macaluso; Serena Fasano; Riccardo Alessandro; Francesco Ciccia
Journal:  Curr Rheumatol Rep       Date:  2019-06-13       Impact factor: 4.592

4.  Single cell analysis of spondyloarthritis regulatory T cells identifies distinct synovial gene expression patterns and clonal fates.

Authors:  Davide Simone; Frank Penkava; Anna Ridley; Stephen Sansom; M Hussein Al-Mossawi; Paul Bowness
Journal:  Commun Biol       Date:  2021-12-14

5.  Role of macrophage-associated chemokines in the assessment of initial axial spondyloarthritis.

Authors:  Xuegang Li; Anqi Liang; Yujie Cui; Juan Liao; Xueling Fang; Shuping Zhong
Journal:  Clin Rheumatol       Date:  2022-07-26       Impact factor: 3.650

Review 6.  Ankylosing spondylitis: an autoimmune or autoinflammatory disease?

Authors:  Daniele Mauro; Ranjeny Thomas; Giuliana Guggino; Rik Lories; Matthew A Brown; Francesco Ciccia
Journal:  Nat Rev Rheumatol       Date:  2021-06-10       Impact factor: 20.543

Review 7.  Barrier lymphocytes in spondyloarthritis.

Authors:  Adam Berlinberg; Kristine A Kuhn
Journal:  Curr Opin Rheumatol       Date:  2020-07       Impact factor: 5.006

8.  Interleukin-17 Inhibition in Spondyloarthritis Is Associated With Subclinical Gut Microbiome Perturbations and a Distinctive Interleukin-25-Driven Intestinal Inflammation.

Authors:  Julia Manasson; David S Wallach; Giuliana Guggino; Matthew Stapylton; Michelle H Badri; Gary Solomon; Soumya M Reddy; Roxana Coras; Alexander A Aksenov; Drew R Jones; Parvathy V Girija; Andrea L Neimann; Adriana Heguy; Leopoldo N Segal; Pieter C Dorrestein; Richard Bonneau; Monica Guma; Francesco Ciccia; Carles Ubeda; Jose C Clemente; Jose U Scher
Journal:  Arthritis Rheumatol       Date:  2020-03-12       Impact factor: 10.995

Review 9.  The gut-joint axis in rheumatoid arthritis.

Authors:  Mario M Zaiss; Hsin-Jung Joyce Wu; Daniele Mauro; Georg Schett; Francesco Ciccia
Journal:  Nat Rev Rheumatol       Date:  2021-03-05       Impact factor: 32.286

10.  CX3CL1-CX3CR1 Axis: A New Player in Coeliac Disease Pathogenesis.

Authors:  Marta Fernández-Prieto; María Jesús Fernández-Aceñero; Natalia López-Palacios; Andrés Bodas; Sergio Farrais; David Cuevas; Virginia Pascual; M Ángeles Cerón-Nieto; Saúl Horta-Herrera; Laura Espino-Paisán; Isabel Salazar; Concepción Núñez
Journal:  Nutrients       Date:  2019-10-23       Impact factor: 5.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.